2023
|
Invention
|
Novel hepatoselective polyadenylating polymerases inhibitors and their method of use. Described h... |
|
Invention
|
Novel diazepines that target yellow fever virus non-structural 4b (ns4b) protein and their method... |
2022
|
Invention
|
Methods, kits and compositions for reducing chromosomal instability in cancer cells.
Described h... |
|
Invention
|
Methods, kits and compositions for reducing chromosomal instability in cancer cells. Described he... |
2021
|
Invention
|
Methods and kits for diagnosing and treating cancers.
Methods and/or kits for aiding, preventing... |
|
Invention
|
Methods and kits for diagnosing and treating cancers. Methods and/or kits for aiding, preventing,... |
|
Invention
|
Bicyclic carboxamide with exocyclic urea derivatives as antivirals for the treatment of hbv infec... |
|
Invention
|
Compounds and compositions for treating hematologic malignancies.
The present disclosure relates... |
|
Invention
|
Compounds and compositions for treating hematologic malignancies. The present disclosure relates,... |
2020
|
Invention
|
Methods, kits and compositions for reducing cardiotoxicity associated with cancer therapies. Desc... |
|
Invention
|
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection.
The present invention ... |
|
Invention
|
Lectin assay for assessing glycoforms as an early marker in disease.
The present invention provi... |
2019
|
Invention
|
Benzamide derivatives as cgas-sting pathway agonists.
Pharmaceutical compositions of the inventi... |
|
Invention
|
Benzamide derivatives as cgas-sting pathway agonists. Pharmaceutical compositions of the inventio... |
2018
|
Invention
|
Functionalized benzamide derivatives as antiviral agents against hbv infection.
Pharmaceutical c... |
|
Invention
|
Modulation of hepatitis b virus cccdna transcription.
The present invention provides small molec... |
|
Invention
|
Tagged hepadnavirus e antigen and its use in screening antiviral substances. The present inventio... |
|
Invention
|
Novel antiviral agents against hbv infection.
The present invention is directed toward novel com... |
2017
|
Invention
|
Substituted aminothiazoles. Described herein are substituted aminothiazoles, compositions compris... |
|
Invention
|
2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars exhibiting glucosidase inhibition a... |
|
Invention
|
Modulation of hepatitis b virus cccdna transcription. The present invention provides small molecu... |
2016
|
Invention
|
Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as i... |
2015
|
Invention
|
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection. The present invention p... |
|
Invention
|
Alkylated imino sugars exhibiting glucosidase inhibition and their method of use. Pharmaceutical ... |
|
Invention
|
Ttp inhibitiors of low density lipprotein secretion for the management of diseases associated wit... |
2014
|
Invention
|
Inhibitors of secretion of hepatitis b virus antigens. Pharmaceutical compositions of the inventi... |
|
P/S
|
Scientific research for medical purposes in the field of hepatitis B and liver cancer |
2013
|
Invention
|
Antiviral agents against hbv infection. The present invention provides novel compounds of formula... |
|
Invention
|
Novel antiviral agents against hbv infection. The present invention is directed toward novel comp... |
|
Invention
|
Functionalized benzamide derivatives as antiviral agents against hbv infection. Novel functionali... |
|
Invention
|
Modulation of hepatitis b virus cccdna transcription. The present disclosure pertains to the disc... |
|
Invention
|
Inhibitors of hepatitis b virus covalently closed circular dna formation and their method of use.... |
|
Invention
|
Benzodiazepine compounds with anti-flavivirus activity. The present invention describes a unique ... |
2012
|
Invention
|
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection. Pharmaceutical composit... |